Effect of high-dose glucocorticosteroid treatment for infantile spasms on quantitative bone parameters later in life

Tal Eidlitz-Markus1, Sarah Kivity, Hadassa Goldberg-Stern

  • 1Department of Pediatrics E/Ambulatory Day Care Center, Schneider Children's Medical Center of Israel, Petach Tikva, Israel. eidlitz@post.tau.ac.il

Insights

Infants treated with high-dose glucocorticosteroids for infantile spasms may experience long-term reduced bone density, particularly in the radius. This highlights the need for ongoing monitoring to prevent bone impairments.

Area of Science:

  • Pediatric Endocrinology
  • Bone Densitometry
  • Pharmacology

Background:

  • Infantile spasms often require treatment with adrenocorticotropic hormone (ACTH) and glucocorticoids.
  • Prolonged high-dose glucocorticosteroid use can have potential long-term adverse effects on bone health.
  • Evaluating the long-term skeletal impact of these treatments is crucial for patient management.

Purpose of the Study:

  • To assess the long-term effects of infantile spasms treatment on bone density.
  • To investigate the relationship between glucocorticosteroid therapy and bone ultrasound parameters in a pediatric cohort.

Main Methods:

  • Quantitative bone ultrasound was performed on 30 patients (age 4.8-33 years) treated for infantile spasms.
  • Bone ultrasound measurements (speed of sound Z-score) were taken on the radius and tibia.
  • Patients had completed treatment with ACTH and glucocorticoids at least 2 years prior to the study.

Main Results:

  • A statistically significant lower mean speed of sound Z-score was observed for the radius (-1.085 ± 1.079, P < .001).
  • The tibia also showed a lower mean speed of sound Z-score (-0.22 ± 1.19), with a significant difference from the reference mean (P = .0022).
  • No significant differences in bone ultrasound Z-scores were found between prepubertal and pubertal/postpubertal age groups.

Conclusions:

  • A high proportion of patients treated for infantile spasms with glucocorticoids exhibit reduced radial bone speed of sound later in life.
  • These findings underscore the importance of long-term follow-up to manage and prevent bone density impairments.
  • Special attention may be needed for non-weight-bearing bones affected by this treatment regimen.